Literature DB >> 11171815

Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease.

M J Carter1, A J Lobo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171815      PMCID: PMC1760132          DOI: 10.1136/gut.48.3.295

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.

Authors:  C R Yates; E Y Krynetski; T Loennechen; M Y Fessing; H L Tai; C H Pui; M V Relling; W E Evans
Journal:  Ann Intern Med       Date:  1997-04-15       Impact factor: 25.391

3.  Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Authors:  M C Dubinsky; S Lamothe; H Y Yang; S R Targan; D Sinnett; Y Théorêt; E G Seidman
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

4.  Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.

Authors:  L Lennard; J S Lilleyman
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

5.  Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.

Authors:  D C Pearson; G R May; G H Fick; L R Sutherland
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

6.  An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease.

Authors:  W J Sandborn; E C Van O; B J Zins; W J Tremaine; D C Mays; J J Lipsky
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.